Robust and validated models to predict high risk of non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel node

References

• Tvedskov TF, Jensen MB, Balslev E, Ejlertsen B, Kroman N. Stage migration after introduction of sentinel lymph node dissection in breast cancer treatment in Denmark: A nationwide study. Eur J Cancer 2011;47:872–8.
   PubMed Web of Science ®Google Scholar
• Croshaw RL, Erb KM, Shapiro-Wright HM, Julian TB. The need for axillary dissection in patients with positive axillary sentinel lymph nodes. Curr Oncol Rep 2011;13:5–10.
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, Ko CY, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 2009;27:2946–53.
   PubMed Web of Science ®Google Scholar
• Yi M, Giordano SH, Meric-Bernstam F, Mittendorf EA, Kuerer HM, Hwang RF, et al. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: Experience from the SEER database. Ann Surg Oncol 2010;17:343–51.
   Google Scholar
• Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): A phase 3 randomised controlled trial. Lancet Oncol 2013;14:297–305.
   PubMed Web of Science ®Google Scholar
• Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA 2011;305:569–75.
   PubMed Web of Science ®Google Scholar
• Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 2010;252:426–32.
   PubMed Web of Science ®Google Scholar
• Pepels MJ, Vestjens JH, de BM, Smidt M, van Diest PJ, Borm GF, et al. Safety of avoiding routine use of axillary dissection in early stage breast cancer: A systematic review. Breast Cancer Res Treat 2011;125:301–13.
   PubMed Web of Science ®Google Scholar
• Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003;10:1140–51.
   PubMed Web of Science ®Google Scholar
• Coutant C, Olivier C, Lambaudie E, Fondrinier E, Marchal F, Guillemin F, et al. Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: A prospective multicenter study. J Clin Oncol 2009;27:2800–8.
   PubMed Web of Science ®Google Scholar
• Houvenaeghel G, Nos C, Giard S, Mignotte H, Esterni B, Jacquemier J, et al. A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J Surg Oncol 2009; 35:690–5.
   PubMed Web of Science ®Google Scholar
• Meretoja TJ, Strien L, Heikkila PS, Leidenius MH. A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement. Ann Surg Oncol 2012;19:567–76.
   PubMed Web of Science ®Google Scholar
• Tvedskov TF, Jensen MB, Lisse IM, Ejlertsen B, Balslev E, Kroman N. High risk of non-sentinel node metastases in a group of breast cancer patients with micrometastases in the sentinel node. Int J Cancer 2012;131:2367–75.
   PubMed Web of Science ®Google Scholar
• Christiansen P, Friis E, Balslev E, Jensen D, Moller S. Sentinel node biopsy in breast cancer: Five years’ experience from Denmark. Acta Oncol 2008;47:561–8.
   PubMed Web of Science ®Google Scholar
• Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002;20:3628–36.
   PubMed Web of Science ®Google Scholar
• Moller S, Jensen MB, Ejlertsen B, Bjerre KD, Larsen M, Hansen HB, et al. The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol 2008;47:506–24.
   PubMed Web of Science ®Google Scholar
• Kwon Y, Ro J, Kang HS, Kim SK, Hong EK, Khang SK, et al. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients. Oncol Rep 2011;25:1063–71.
   PubMed Web of Science ®Google Scholar
• Tvedskov TF, Bartels A, Jensen MB, Paaschburg B, Kroman N, Balslev E, et al. Evaluating TIMP-1, Ki67, and HER2 as markers for non-sentinel node metastases in breast cancer patients with micrometastases to the sentinel node. APMIS 2011;119:844–52.
   PubMed Web of Science ®Google Scholar
• Houvenaeghel G, Bannier M, Nos C, Giard S, Mignotte H, Jacquemier J, et al. Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: Nomogram validation and comparison with other models. Breast 2012;21:204–9.
   PubMed Web of Science ®Google Scholar
• Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ. Strategies for subtypes – dealing with the diversity of breast cancer: Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer2011. Ann Oncol 2011;22:1736–47.
   PubMed Web of Science ®Google Scholar
• Pepels MJ, de BM, Bult P, van Dijck JA, van Deurzen CH, Menke-Pluymers MB, et al. Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells. Ann Surg 2012;255:116–21.
   PubMed Web of Science ®Google Scholar
• Noguchi M. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer. Eur J Surg Oncol 2008;34:129–34.
   PubMed Web of Science ®Google Scholar
• Andersson Y, Frisell J, de BJ, Bergkvist L. Prediction of non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastases: Evaluation of the tenon score. Breast Cancer (Auckl.) 2012;6:31–8.
   PubMedGoogle Scholar
• Hessman CJ, Naik AM, Kearney NM, Jensen AJ, Diggs BS, Troxell ML, et al. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer. Arch Surg 2011; 146:1035–40.
   PubMedGoogle Scholar
• Kocsis L, Svebis M, Boross G, Sinko M, Maraz R, Rajtar M, et al. Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients. Am Surg 2004;70:1019–24.
   PubMed Web of Science ®Google Scholar
• Chen K, Zhu L, Jia W, Rao N, Fan M, Huang H, et al. Validation and comparison of models to predict non-sentinel lymph node metastasis in breast cancer patients. Cancer Sci 2011;103:274–81.
   PubMed Web of Science ®Google Scholar